Integrative Healthcare Symposium cancer and chronic Lyme disease

P and T

Volumn 34, Issue 4, 2009, Pages

  Alexander, Walter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; CALCIUM; CAPECITABINE; CARBOPLATIN; CARDIOLIPIN; CARNITINE; CEFUROXIME; CISPLATIN; CURCUMIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; DOXYCYCLINE; FISH OIL; FLUOROURACIL; FOLINIC ACID; GLUTAMINE; MELATONIN; MITOMYCIN C; NICOTINIC ACID; PACLITAXEL; PURINE NUCLEOSIDE; RIBOFLAVIN; RIBOSOME RNA; TAMOXIFEN; TAMOXIFEN CITRATE; UBIDECARENONE; UNINDEXED DRUG;

ADVANCED CANCER; ALLERGY; ALTERNATIVE MEDICINE; AMINO ACID BLOOD LEVEL; ANDROGRAPHIS; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRALGIA; AUTONOMIC NEUROPATHY; BLEEDING; BONE METASTASIS; BORRELIA BURGDORFERI; BRAIN HEMORRHAGE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER THERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CELL PROTECTION; CHILL; CHRONIC DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; COGNITIVE DEFECT; COLON CANCER; CONFERENCE PAPER; CONSCIOUSNESS; DAILY LIFE ACTIVITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG SELF ADMINISTRATION; DYSESTHESIA; ENDOCRINE DISEASE; ENVIRONMENTAL HEALTH; ENZYME DEFICIENCY; ENZYME INHIBITION; FEVER; GAIT DISORDER; GASTROINTESTINAL DISEASE; GINKGO BILOBA; HEALTH CARE; HEALTH CARE PERSONNEL; HEART PROTECTION; HEAVY METAL REMOVAL; HERBAL MEDICINE; HUMAN; INFLAMMATION; JOINT SWELLING; LIVER DISEASE; LUNG CANCER; LYME DISEASE; MEDICAL SPECIALIST; MICROBIAL IDENTIFICATION; MITOCHONDRION; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; MYALGIA; NEOPLASM; NEUROTOXICITY; NUTRITION; NUTRITIONAL DEFICIENCY; PANCREAS CANCER; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSICIAN; POLYGONUM; PSYCHOLOGICAL ASPECT; RASH; RELAPSE; RELIGION; RISK FACTOR; SARSAPARILLA; SLEEP DISORDER; STEPHANIA; TEA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TICK BORNE DISEASE; TOXICITY; WESTERN BLOTTING; WOMEN'S HEALTH;

EID: 66949173357     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. 10 in preventing in vitro doxorubicinrelated cardiac damages. Oncology 1988;45 (3): 242-246.
2. Sugiyama S, Yamada K, Hayakawa M, et al. Approaches that mitigate doxorubicin-induced delayed adverse effects on mitochondrial functions in rat hearts: Liposome-encapsulated doxorubicin or combination therapy with antioxidant. Biochem Mol Biol Int 1995;36:1001-1007.
3. 10 for prevention of anthracyclineinduced cardiotoxicity (Review). Integr Cancer Ther 2005;4 (2): 110-130.
4. Arrigoni-Martelli E, Caso V. Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exp Clin Res 2001; 27 (1): 27-49.
5. Graziano F, Bisonni R, Catalano V, et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer 2002; 86 (12): 1854-1857.
6. Somasundaram S, Edmund NA, Moore, DT, et al. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 2002;62:3868-3875.
7. Vahdat L, Papadopoulos K, Lange D, et al. Reduction of paclitaxelinduced peripheral neuropathy with glutamine. Clin Cancer Res 2001;7:1192-1197.
8. Argyriou AA, Chroni e, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial. Neurology 2005;64:26-31.
9. Alschuler L, Gazella K (eds.). Alternative Medicine Magazine's Definitive Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing, 2nd ed. Celestial Arts/Ten Speed Press; 2007.